Delivery Order SPE2DB24D3015-SPE2DB25FFZRJ

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,050.91, is for the delivery of Terbinafine HCL 250 mg tablets. The contract is a firm-fixed-price delivery order with a performance period ending on May 8, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a $2,111.45 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,142,806 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The award is not set-aside and has an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of Terbinafine HCL 250 MG Tablet 30S, a medication, with a firm fixed price ceiling value of $1,920.72 and a completion date of May 20, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Terbinafine HCL 250 mg tablets in 30-count packages. The contract has a ceiling value of $32,679.41 and a completion date of May 15, 2025. It is a firm-fixed-price contract, indicating that the agreed-upon price will not change. The contract is not set aside for any specific...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,242.75, is for the delivery of 4,566,687,575 units of terbinafine hydrochloride 250 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 12, 2024. The award is not associated with a set-aside designation. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,329.90, is for the delivery of Terbinafine HCL 250 MG Tablets in 30-count packages. The contract is a firm fixed-price delivery order with a completion date of May 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 100 tablets of the medication terbinafine hydrochloride 250 mg. The contract has a ceiling value of $1,534.95, is a firm fixed price delivery order, and has an ultimate completion date of May 29, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a substantial Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract, with a ceiling value of $92,164.85, is for the delivery of terbinafine hydrochloride 250 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Terbinafine HCL 250 MG Tablet 30S. The contract is a Firm Fixed Price, non-set-aside award with a ceiling value of $1,618.04 and a period of performance ending on May 29, 2025. Amerisourcebergen Drug Corp is also an awardee on a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,971.41 firm fixed-price delivery order is for the supply of 4,568,188,746 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has a performance period through May 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZRJ
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,268.93, is for the supply of Terbinafine Hydrochloride 250 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition. AmerisourceBergen, as the prime contractor, is responsible for delivering the requested pharmaceutical product to fulfill the government's medical supply requirements, particularly in support of military and veteran healthcare programs.

Generated 9/3/25, 10:00 AM